drug resistance
254 projects
H2020Individual fellowship2016–2018United Kingdom
KILLINGTYPHI · Identification of host-factors restricting Salmonella Typhi
H2020Individual fellowship2016–2018Switzerland
PepPtNPAntiCan · Peptide Coated Platinum Nanoparticles as Antitumor Agents
H2020Individual fellowship2016–2018Denmark
PYANO · Retargeted Pyocins: A novel tool for combating major food borne pathogens and exploiting phage-host interactions
H2020Individual fellowship2016–2018Portugal
a-Sign · Cyclic nucleotide signalling in the human pathogen Listeria monocytogenes
H2020Staff exchange2016–2019France
PANG · Pathogen and Graphene
8 partners · 6 countries
H2020Doctoral network2016–2020Belgium
ND4ID · New Diagnostics for Infectious Diseases: “ND4ID”
23 partners · 10 countries
H2020Individual fellowship2016–2018United Kingdom
T6SS-PSEUDO-LIP · Type VI-dependent Pseudomonas aeruginosa phospholipases and host manipulation
H2020Individual fellowship2016–2018United Kingdom
BATTLE · The molecular basis of NleB-mediated bacterial virulence
H2020Individual fellowship2016–2018Germany
GDA in staphylococci · Gen Duplication and Amplification in Staphylococcal populations
H2020Individual fellowship2016–2018Netherlands
Inflammafish · Cross-talk between inflammation and autophagy in tuberculosis
H2020Doctoral network2015–2019Italy
GLYCOVAX · A training network for the rational design of the next generation of well-defined glycoconjugate vaccines
12 partners · 8 countries
H2020Doctoral network2015–2019United Kingdom
HaemMetabolome · Deciphering the Metabolism of Haematological Cancers
7 partners · 4 countries
H2020Individual fellowship2015–2018United Kingdom
QuantPalm_immunity · Quantitative analysis of protein S-palmitoylation in host resistance to intracellular pathogens.
2 partners · 2 countries
H2020Doctoral network2015–2019Germany
IMMUTRAIN · Training Network for the Immunotherapy of Cancer
10 partners · 8 countries
H2020Individual fellowship2015–2017Italy
SVNanoVax · Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy
H2020Individual fellowship2015–2017United Kingdom
NOVENA · Exploiting an unusual polyketide chain release mechanism for production of novel enacyloxin antibiotic analogues
H2020Individual fellowship2015–2017Sweden
ACT against AMR · Abyssomicin C Truncated derivatives against Antimicrobial Resistance
H2020Individual fellowship2015–2017France
MDR Tuberculosis · Evolution and success of the multi-drug resistant M. tuberculosis SIT41 (LAM7-TUR) lineage
H2020Individual fellowship2015–2017Hungary
BARREL · Barrel Assemblies of Membrane Active Artificial Foldamers
H2020Individual fellowship2015–2017Ireland
GENOLACT · Consolidating a genomic framework for exploiting lactobacilli
H2020Individual fellowship2015–2017United Kingdom
BactoDrug · The Bacteroides dual-pumping membrane-integral pyrophosphatase: a novel drug target
H2020Individual fellowship2015–2017Netherlands
AND · Antibacterial (Nano)medicines Development
H2020Individual fellowship2015–2017United Kingdom
PEARS · Predicting the Evolution of Antibiotic Resistance in Streptococcus pneumoniae
H2020Individual fellowship2015–2018United Kingdom
BURK-6 · Investigation of the Type VI secretion system-associated toxins of Burkholderia thailandensis
2 partners · 2 countries
